The online version of this article (https://doi.org/10.1007/s11764-018-0713-9) contains supplementary material, which is available to authorized users.
Belle H. de Rooij and Teresa Hagan Thomas contributed equally to this work.
This qualitative study sought to describe the challenges following treatment and the preferences regarding survivorship care among patients treated for gynecological cancer, their caregivers, and health care providers.
Between July and August 2017, in-depth semi-structured interviews regarding survivorship were conducted at a large academic hospital in the USA among patients who recently completed treatment (< 12 months) for a gynecological cancer (ovarian, endometrial, cervical, and vulvar) and their primary caregivers. A focus group was conducted among health care providers (oncologists, nurses, and fellows). Main themes were identified using descriptive content analysis.
A total of 30 individuals participated in this study (13 patients, 9 caregivers, 8 health care providers). Almost all participants reported a desire for more information on how to address survivorship needs, specifically as they related to side effects, follow-up schedule, and psychological assistance. Despite this uniformly identified need for more information, preferences for survivorship care planning differed across cancer types and individuals, with respect to content, timing, and mode of delivery. Health care providers expressed challenges in communicating with patients about survivorship, a desire to shift post-treatment conversations to the goal of improving quality of life as opposed to focusing on disease recurrence, and an unmet need for disease specific and individualized survivorship care planning.
Patients, caregivers, and health care providers each expressed a need for gynecologic cancer-tailored survivorship care resources.
The variation of disease types and patient and caregiver needs may require multi-faceted, individualized survivorship care planning.
ESM 1 (DOCX 44 kb)11764_2018_713_MOESM1_ESM.docx
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.
Donovan HS, Hartenbach EM, Method MW. Patient-provider communication and perceived control for women experiencing multiple symptoms associated with ovarian cancer. Gynecol Oncol. 2005;99(2):404–11. https://doi.org/10.1016/j.ygyno.2005.06.062. CrossRefPubMed
Ferrell B, Smith S, Cullinane C, Melancon C. Symptom concerns of women with ovarian cancer. J Pain Symptom Manag. 2003;25(6):528–38. CrossRef
Matulonis UA, Kornblith A, Lee H, Bryan J, Gibson C, Wells C, et al. Long-term adjustment of early-stage ovarian cancer survivors. Int J Gynecol Cancer. 2008;18(6):1183–93. https://doi.org/10.1111/j.1525-1438.2007.01167.x.CrossRefPubMed
Mirabeau-Beale KL, Kornblith AB, Penson RT, Lee H, Goodman A, Campos SM, et al. Comparison of the quality of life of early and advanced stage ovarian cancer survivors. Gynecol Oncol. 2009;114(2):353–9. https://doi.org/10.1016/j.ygyno.2009.05.009. CrossRefPubMed
Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in translation. Committee on Cancer Survivorship: Improving Quality Care and Quality of Life, National Cancer Policy Board. Washington, DC: National Academies Press; 2006.
Nicolaije KA, Ezendam NP, Vos MC, Pijnenborg JM, Boll D, Boss EA, et al. Impact of an automatically generated cancer survivorship care plan on patient-reported outcomes in routine clinical practice: longitudinal outcomes of a pragmatic, cluster randomized trial. J Clin Oncol. 2015;33(31):3550–9. CrossRefPubMed
de Rooij BH, Ezendam NPM, Nicolaije KAH, Caroline Vos M, Pijnenborg JMA, Boll D, et al. Effects of survivorship care plans on patient reported outcomes in ovarian cancer during 2-year follow-up—the ROGY care trial. Gynecol Oncol. 2017;145(2):319–28. https://doi.org/10.1016/j.ygyno.2017.02.041. CrossRefPubMed
Nekhlyudov L, Ganz PA, Arora NK, Rowland JH. Going beyond being lost in transition: a decade of progress in cancer survivorship. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017;35(18):1978–81. https://doi.org/10.1200/JCO.2016.72.1373. CrossRef
de Rooij BH, Ezendam NP, Nicolaije KA, Lodder P, Vos MC, Pijnenborg JM, et al. Survivorship care plans have a negative impact on long-term quality of life and anxiety through more threatening illness perceptions in gynecological cancer patients: the ROGY care trial. Qual Life Res. 2018;27(6):1533–44.
Nicolaije KA, Ezendam NP, Pijnenborg JM, Boll D, Vos MC, Kruitwagen RF, et al. Paper-based survivorship care plans may be less helpful for cancer patients who search for disease-related information on the internet: results of the Registrationsystem Oncological Gynecology (ROGY) Care randomized trial. J Med Internet Res. 2016;18(7):e162. CrossRefPubMedPubMedCentral
Nicolaije KA, Husson O, Ezendam NP, Vos MC, Kruitwagen RF, Lybeert ML, et al. Endometrial cancer survivors are unsatisfied with received information about diagnosis, treatment and follow-up: a study from the population-based PROFILES registry. Patient Educ Couns. 2012;88(3):427–35. https://doi.org/10.1016/j.pec.2012.05.002. CrossRefPubMed
- Survivorship care planning in gynecologic oncology—perspectives from patients, caregivers, and health care providers
Belle H. de Rooij
Teresa Hagan Thomas
Kathryn E. Post
Nicole P. M. Ezendam
Don S. Dizon
- Springer US
- Journal of Cancer Survivorship
Research and Practice
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267